[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertise Here
October 4, 2010
Volume 88, Number 40
p. 8

Perturbing A Cancer Reader

Chemical Biology: Locking a protein that recognizes markers on chromatin shrinks tumors in mice

Carmen Drahl

Block On (+)-JQ1 (mostly yellow) interacts with a pocket on BRD4 (mostly pink) through a hydrogen bond (dotted line). Panagis Filippakopoulos
Block On (+)-JQ1 (mostly yellow) interacts with a pocket on BRD4 (mostly pink) through a hydrogen bond (dotted line).
  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

By targeting a specific protein pocket, researchers have found a way to block a protein motif that reads chemical marks on genetic material that regulates the transcription of genes. The strategy could lead to new treatments for cancer and other diseases.

Until recently, scientists have focused on regulating proteins that add or remove so-called epigenetic marks, such as histone deacetylase enzymes. Now, chemical biologists Jun Qi and James E. Bradner of Dana-Farber Cancer Institute and Harvard Medical School, structural biologist Stefan Knapp of Oxford University and the Structural Genomics Consortium, and colleagues have found a way to block the activity of a protein module called BRD4, which neither adds nor removes but instead “reads” lysine acetylation marks on genetic material (Nature, DOI: 10.1038/nature09504).


They discovered (+)-JQ1, a molecule that nestles in a largely hydrophobic pocket on BRD4, preventing the protein-protein interaction between BRD4 and acetylated histone proteins in chromatin. Giving (+)-JQ1 to mice with an aggressive and rare form of cancer in which BRD4 becomes part of an abnormal, fused protein led to tumor death.

“We consider JQ1 a tool compound,” Knapp says. “It allows us to study how these readers participate in the development of disease.” Dana-Farber has filed for patents on (+)-JQ1 derivatives that might inspire drugs to treat diseases.

Efforts “like this ultimately lay the foundation for clinical studies, and I think this work is an important step toward that,” says Philip A. Cole, who studies gene regulation at Johns Hopkins University School of Medicine.

GlaxoSmithKline researchers led by Kevin Lee presented a similar strategy for blocking epigenetic readers in August at the ACS national meeting in Boston. “This paper shows the promise and potential of inhibition of the reader domains within epigenetics,” Lee says.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!